LATECOERE (LAT.PA)

FR001400JY13 - Common Stock

0.013  +0 (+0.78%)

Fundamental Rating

1

LAT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 38 industry peers in the Aerospace & Defense industry. LAT may be in some trouble as it scores bad on both profitability and health. LAT is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

LAT had negative earnings in the past year.
In the past year LAT has reported a negative cash flow from operations.
In the past 5 years LAT reported 4 times negative net income.
In the past 5 years LAT reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -17.69%, LAT is doing worse than 91.89% of the companies in the same industry.
Industry RankSector Rank
ROA -17.69%
ROE N/A
ROIC N/A
ROA(3y)-23.52%
ROA(5y)-14.95%
ROE(3y)-396.82%
ROE(5y)-240.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of LAT (36.63%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of LAT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for LAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.07%
GM growth 5Y-0.89%

0

2. Health

2.1 Basic Checks

LAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LAT has more shares outstanding
Compared to 5 years ago, LAT has more shares outstanding
LAT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.36, we must say that LAT is in the distress zone and has some risk of bankruptcy.
LAT has a worse Altman-Z score (-0.36) than 89.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACC4.83%

2.3 Liquidity

LAT has a Current Ratio of 0.99. This is a bad value and indicates that LAT is not financially healthy enough and could expect problems in meeting its short term obligations.
LAT has a Current ratio of 0.99. This is amonst the worse of the industry: LAT underperforms 83.78% of its industry peers.
LAT has a Quick Ratio of 0.99. This is a bad value and indicates that LAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.47, LAT is doing worse than 89.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.47

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.96% over the past year.
The Revenue has grown by 41.00% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.56% on average over the past years.
EPS 1Y (TTM)39.96%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q77.95%
Revenue 1Y (TTM)41%
Revenue growth 3Y-13.08%
Revenue growth 5Y-6.56%
Revenue growth Q2Q43.01%

3.2 Future

LAT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.87% yearly.
The Revenue is expected to grow by 18.87% on average over the next years. This is quite good.
EPS Next Y-134.59%
EPS Next 2Y-45.86%
EPS Next 3Y-22.87%
EPS Next 5YN/A
Revenue Next Year32.83%
Revenue Next 2Y24.05%
Revenue Next 3Y18.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

LAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LAT indicates a rather expensive valuation: LAT more expensive than 81.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.84

4.3 Compensation for Growth

A cheap valuation may be justified as LAT's earnings are expected to decrease with -22.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.86%
EPS Next 3Y-22.87%

0

5. Dividend

5.1 Amount

No dividends for LAT!.
Industry RankSector Rank
Dividend Yield N/A

LATECOERE

EPA:LAT (4/19/2024, 7:00:00 PM)

0.013

+0 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap162.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.69%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 36.63%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.99
Quick Ratio 0.47
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.96%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-134.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)41%
Revenue growth 3Y-13.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y